title: The Importance of Body Surface Area at Baseline and during Treatment in Chronic Myeloid Leukemia Patients Treated with Imatinib.
authors: Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
authors: Massimo
authors: M
authors: Breccia
authors: Matteo
authors: M
authors: Molica
authors: Gioia
authors: G
authors: Colafigli
authors: Giuliana
authors: G
authors: Alimena
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides / Q000008:administration & dosage*; D001830:Body Surface Area; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate